# ACute and Chronic Effects of Saxagliptin

> **NCT01521312** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 24 (actual)

## Conditions studied

- Impaired Glucose Tolerance

## Interventions

- **DRUG:** saxagliptin
- **OTHER:** placebo pill

## Key facts

- **NCT ID:** NCT01521312
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2015-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521312, "ACute and Chronic Effects of Saxagliptin". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01521312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*